KEYWORD

UCI MIND

UCI Podcast Indicator

UCI Podcast: The latest on Alzheimer’s disease

UCI MIND’s Dr. Joshua Grill talks about two new drugs and a whole lot more

Students from Santa Ana and Anaheim high schools learn about neuroanatomy as part of the UCI MIND Beall Scholar Program to Inspire Future STEM Leaders.

Support from Joan and Don Beall will sustain two UCI MIND programs

Funding will advance educational outreach in Orange County and early career research

Joshua Grill (left) and Marina Ritchie

Controversial Alzheimer’s drug approval sparks surprising impact

UCI MIND survey finds media coverage swayed clinical trial volunteers

microscopic image of cells

UCI School of Biological Sciences to host lecture on Alzheimer’s

Five experts will discuss past, present and future of the disease

The UCI research team is directed by (seated, from left) Frank LaFerla, Andrea Tenner and Kim Green. Other investigators include (standing, from left) Marcelo Wood, Arthur Lander, Grant MacGregor, Ian Smith, Vivek Swarup, Craig Stark, Andre Obenaus and Ali Mortazavi.

UCI Alzheimer’s project wins $47 million grant from National Institute on Aging

Scientists will develop mouse models to help unravel most common form of disease

UCI researchers aim to diversify clinical research participation with $3.7 million NIH grant

The multidisciplinary team will focus on participant recruitment and retainment for Alzheimer’s disease and related disorders research

Behind a good mutation: How a gene variant protects against Alzheimer’s

UCI study provides first evidence about how this protective mutation may reduce disease risk

Frank LaFerla
UCI Podcast Indicator

Coping with memory impairment during the holidays

School of Biological Sciences Dean Frank La Ferla offers advice for family members

Jean Ho, postdoc, and psychological science professor Daniel Nation photo: Steve Zylius/UCI

UCI-led meta-analysis identifies hypertension medications that help ward off memory loss

People taking drugs that cross the blood-brain barrier experienced less cognitive decline

New mouse model provides first platform to study late-onset Alzheimer’s disease

First-of-its-kind advance holds promise for making new strides in research, treatments